<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tamayo LI</submitter><funding>National Institute of Environmental Health Sciences</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>e1011826</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12404487</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>In Bangladesh, > 50 million individuals are chronically exposed to inorganic arsenic (iAs) through drinking water, increasing risk for cancer and other iAs-related diseases. Previous studies show that individuals' ability to metabolize and eliminate iAs, and their risk of toxicity, is influenced by genetic variation in the AS3MT and FTCD gene regions.&lt;h4>Methods&lt;/h4>To identify additional loci influencing arsenic metabolism, we used data from Bangladeshi individuals to conduct genome-wide association analyses of the relative abundances of arsenic species measured in both urine (n = 6,540) and blood (n = 976). These species include iAs, monomethylated arsenic (MMA) and dimethylated arsenic (DMA) species.&lt;h4>Results&lt;/h4>In analyses of urine arsenic species, we identified a</pubmed_abstract><journal>PLoS genetics</journal><pubmed_title>Genetic variation in the FMO and GSTO gene clusters impacts arsenic metabolism in humans.</pubmed_title><pmcid>PMC12404487</pmcid><funding_grant_id>P30 ES027792</funding_grant_id><funding_grant_id>R21 ES035491</funding_grant_id><funding_grant_id>R35 ES028379</funding_grant_id><funding_grant_id>R01 DK123285</funding_grant_id><pubmed_authors>Davydiuk T</pubmed_authors><pubmed_authors>Islam T</pubmed_authors><pubmed_authors>Vander Griend D</pubmed_authors><pubmed_authors>Tong L</pubmed_authors><pubmed_authors>Kibriya MG</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Tamayo LI</pubmed_authors><pubmed_authors>Haque SE</pubmed_authors><pubmed_authors>Ahsan H</pubmed_authors><pubmed_authors>Gamble MV</pubmed_authors><pubmed_authors>Le XC</pubmed_authors><pubmed_authors>Jasmine F</pubmed_authors><pubmed_authors>Graziano J</pubmed_authors><pubmed_authors>Pierce BL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic variation in the FMO and GSTO gene clusters impacts arsenic metabolism in humans.</name><description>&lt;h4>Background&lt;/h4>In Bangladesh, > 50 million individuals are chronically exposed to inorganic arsenic (iAs) through drinking water, increasing risk for cancer and other iAs-related diseases. Previous studies show that individuals' ability to metabolize and eliminate iAs, and their risk of toxicity, is influenced by genetic variation in the AS3MT and FTCD gene regions.&lt;h4>Methods&lt;/h4>To identify additional loci influencing arsenic metabolism, we used data from Bangladeshi individuals to conduct genome-wide association analyses of the relative abundances of arsenic species measured in both urine (n = 6,540) and blood (n = 976). These species include iAs, monomethylated arsenic (MMA) and dimethylated arsenic (DMA) species.&lt;h4>Results&lt;/h4>In analyses of urine arsenic species, we identified a</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-29T17:33:24.285Z</modification><creation>2026-04-08T05:38:14.929Z</creation></dates><accession>S-EPMC12404487</accession><cross_references><pubmed>40892834</pubmed><doi>10.1371/journal.pgen.1011826</doi></cross_references></HashMap>